StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
This year
1
Publishing Date
2024 - 03 - 26
1
2021 - 05 - 04
1
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 14
1
2021 - 03 - 22
1
2021 - 03 - 15
1
2021 - 03 - 12
1
2021 - 02 - 01
1
2020 - 12 - 02
1
Sector
Health technology
10
Tags
Alliances
16
Antibody
7
Application
11
Approval
20
Asia
15
Biotech
6
Biotech-bay
10
Biotech-beach
17
Cabometyx
7
Cancer
34
Cell carcinoma
7
Children
7
Clinical-trials-phase-ii
10
Clinical-trials-phase-iii
23
Collaboration
15
Covid
11
Covid-19
10
Disease
33
Drug
29
Earnings
23
Events
8
Expected
7
Fda
17
Financial
17
Financial results
13
Gene therapies
6
Gene therapy
6
Genetown
22
Global
51
Growth
29
Hereditary angioedema
8
Injection
6
Japan
7
License
13
Liver
16
Market
85
Money
11
N/a
185
Nivolumab
6
Partnership
6
People
7
Pharmaceutical
17
Phase 2
6
Phase 3
19
Positive
14
Product-news
10
Rare
11
Reach
12
Renal
7
Report
46
Research
41
Results
58
Sars-cov-2
6
Study
8
Takhzyro
7
Therapeutics
37
Therapy
43
Treatment
50
Trial
36
Vaccine
27
Entities
Bristol-myers squibb company
1
Exelixis, inc.
1
Incyte corporation
1
Johnson & johnson
1
Karyopharm therapeutics inc.
1
Morphosys ag
1
Novartis ag
1
Sanofi
1
Takeda pharmaceutical company limited
10
Xencor, inc.
1
Symbols
A
6
ABBV
4
ABCL
4
ABT
5
ADCT
3
AGEN
3
AMGN
6
AMRS
4
ANIX
5
APDN
6
AVGR
5
AVRO
3
AXNX
3
AYTU
3
BDX
5
BGNE
9
BMY
14
BRKR
8
BSX
4
CDNA
6
CODX
4
CSII
3
CSTL
3
EDSA
3
ENDP
4
EPIX
3
EXEL
5
GILD
3
GNPX
3
GSK
4
HOTH
5
IMAB
6
INCY
7
JNJ
57
LEXX
4
LH
4
LLY
17
LPCN
4
MDT
7
MOTS
4
MRK
9
MRNA
13
MS
4
MYGN
4
NAOV
4
NVS
5
OMER
4
PFE
10
PKI
4
PTE
7
QDEL
4
SEEL
6
SNY
36
SNYNF
6
TAK
10
TECH
8
TMO
5
TNXP
4
TWST
9
XNCR
4
Exchanges
Nasdaq
4
Nyse
10
Crawled Date
2024 - 03 - 26
1
2021 - 05 - 04
1
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 15
1
2021 - 03 - 22
1
2021 - 03 - 15
1
2021 - 03 - 12
1
2021 - 02 - 01
1
2020 - 12 - 02
1
Crawled Time
00:00
1
09:00
2
11:00
1
12:00
1
12:15
1
13:00
2
15:00
1
18:00
1
Source
www.biospace.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Product-news
symbols :
TAK
save search
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published:
2024-03-26
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.07%
|
O:
1.84%
H:
0.24%
C:
-0.14%
adzynma
japan
takeda
approval
injection
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2021-05-04
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-21.91%
|
O:
-0.12%
H:
0.0%
C:
-1.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
7.74%
|
O:
-0.82%
H:
0.28%
C:
-0.06%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-56.2%
|
O:
-0.96%
H:
0.0%
C:
-5.61%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
-24.06%
|
O:
-4.71%
H:
0.33%
C:
-2.65%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-38.24%
|
O:
-2.37%
H:
2.04%
C:
-2.95%
financial results
results
Karyopharm Announces European Medicines Agency's Validation of its Type II Variation Marketing Authorization Application for NEXPOVIO®
Published:
2021-04-26
(Crawled : 12:15)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.92%
|
O:
0.23%
H:
0.47%
C:
-0.53%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-86.37%
|
O:
-0.11%
H:
5.12%
C:
4.58%
europe
authorized
application
Global Roundup: Phico Therapeutics Wins CARB-X Funding for Bacteriophage Drug
Published:
2021-04-22
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.28%
|
O:
1.24%
H:
0.0%
C:
-0.64%
funding
drug
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Published:
2021-04-14
(Crawled : 00:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.65%
|
O:
0.0%
H:
1.09%
C:
0.35%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.03%
|
O:
0.27%
H:
0.33%
C:
0.09%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-1.69%
|
O:
-0.38%
H:
4.2%
C:
3.09%
treatment
europe
renal
approval
cell carcinoma
nivolumab
Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance
Published:
2021-03-22
(Crawled : 11:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-33.62%
|
O:
-0.56%
H:
1.35%
C:
1.02%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.83%
|
O:
-1.64%
H:
1.2%
C:
0.39%
drug discovery
drug
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Published:
2021-03-15
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-28.69%
|
O:
1.36%
H:
1.12%
C:
0.96%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.18%
|
O:
0.09%
H:
0.57%
C:
0.42%
covid
vaccine
covid-19
Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for Hereditary Angioedema Attacks
Published:
2021-03-12
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-29.03%
|
O:
-1.13%
H:
0.76%
C:
0.66%
new drug
treatment
drug
application
hereditary angioedema
Takeda Completes Sale of TachoSil® to Corza Health
Published:
2021-02-01
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-25.41%
|
O:
1.13%
H:
0.11%
C:
-0.45%
sales
health
Takeda Further Enables Hemophilia A Personalized Care With Launch of myPKFiT® Software for ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated]
Published:
2020-12-02
(Crawled : 15:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-26.86%
|
O:
1.45%
H:
1.23%
C:
0.55%
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.